| 降纤酶与巴曲酶治疗缺血性脑血管病的临床观察 |
| |
| 引用本文： | 葛余浩,王子先. 降纤酶与巴曲酶治疗缺血性脑血管病的临床观察[J]. 中国临床保健杂志, 1998, 0(1) |
| |
| 作者姓名： | 葛余浩 王子先 |
| |
| 作者单位： | 安徽省立医院 230001(葛余浩)，安徽省立医院 230001(王子先) |
| |
| 摘 要： | 目的:评价降纤酶治疗ICVD的疗效及安全性方法:治疗组29例,采用兆科降纤酶5Bμ静滴每天一次,共5天,对照组27例采用巴曲酶第1天10Bμ,第3、第5天均用5Bμ静滴,共3次。结果两组总有效率分别为93.1％(降纤酶组)和96.3％(巴曲酶组)(P>0.05),两组间血液流变学参数变化无显著差异(P>0.05),两组均无明显不良反应。结论 国产兆科降纤酶与进口巴曲酶治疗ICVD疗效及安全性相近。
|
| 关 键 词： | 蛇毒凝血酶类 巴曲抗栓酶 ICVD 流变学 |
Defibrase VS batroxobin(DF-521)in treating ischemia cerebral vascular disease (ICVD) |
| |
| GE YuHao Wang zixian Anhui Provincial Hospital Hefei. Defibrase VS batroxobin(DF-521)in treating ischemia cerebral vascular disease (ICVD)[J]. Chinese Journal of Clinical Healthcare, 1998, 0(1) |
| |
| Authors: | GE YuHao Wang zixian Anhui Provincial Hospital Hefei |
| |
| Affiliation: | GE YuHao Wang zixian Anhui Provincial Hospital Hefei 230001 |
| |
| Abstract: | Objective TO evaluate the efficacy and safety of defibrase in treatingICVD, Methods Thetreatment group of29 patients were treated with zhaoke defibrase 5BU , iv drip qd for 5d ; The other 27 patients in control group were treated with Batroxobin(DF-521)first dose 10BU, d3 and d5 both with 5BU iv drip. Results The total effective rate was 93. 1% in former group and 96. 3% in latter group(P>0. 05) ; The improvements of the hemorrheology parameter between two groups were no significant difference; And notable adverse reaction was not observed Concluston The efficacy and safety of domestic zhaoke defibrase and imported Batroxobin(DF-512) are similar |
| |
| Keywords: | Reptilase batroxobin ICVD Rhelogy |
| 本文献已被 CNKI 等数据库收录！ |
